Physician profile
Al C Kline
NPI 1932181872
$2,774.81
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2020: $167 · 2021: $38.81 · 2022: $479 · 2023: $23.14 · 2024: $88.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,663.11 | 2019 | |
| Stryker Corporation | $487.77 | 2019-2022 | |
| Trilliant Surgical LLC. | $259.47 | 2019-2020 | |
| Abbvie INC. | $114.18 | 2022-2024 | |
| Melinta Therapeutics, LLC | $39.41 | 2021-2022 | |
| Medline Industries LP | $33.37 | 2020-2022 | |
| Sebela Pharmaceuticals INC. | $30.22 | 2019 | |
| Bioventus LLC | $25.71 | 2019 | |
| Treace Medical Concepts, INC. | $24.23 | 2022 | |
| Smith+Nephew, INC. | $23.61 | 2019 | |
| Baudax Bio INC. | $21.95 | 2021 | |
| Amgen INC. | $20.97 | 2024 | Krystexxa |
| Amniox Medical, INC. | $16.00 | 2020 | |
| Organogenesis INC. | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Al Kline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.